Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
TCBP | US
-2.79
-55.14%
Healthcare
Biotechnology
31/03/2024
21/10/2024
2.27
4.97
5.04
1.89
TC Biopharm (Holdings) Plc a clinical-stage biopharmaceutical company focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune an allogeneic unmodified gamma-delta T cell therapy product used in the treatment of acute myeloid leukemia; and ImmuniStim an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell the United Kingdom.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
High Current Volume and Negative 1-Day Return
Microcap (<300M USD)
High Debt to Equity (> 0.75)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
274.6%1 month
250.1%3 months
214.4%6 months
160.9%-
-
2.06
1.31
0.20
-0.17
1.83
-
-12.92M
1.30M
1.30M
-
-
-86.80
188.60
-1.22K
0.05
3.50
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
6.36
Range1M
6.36
Range3M
9.01
Rel. volume
9.18
Price X volume
6.90M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Arch Therapeutics Inc | ARTH | Biotechnology | 0.3002 | 1.33M | 0.00% | n/a | 0.00% |
Evofem Biosciences Inc | EVFM | Biotechnology | 0.0092 | 923.03K | -8.00% | 0.00 | 0.00% |
Seelos Therapeutics Inc | SEEL | Biotechnology | 1.13 | 832.04K | 11.88% | 0.00 | -36.10% |
International Stem Cell Corporation | ISCO | Biotechnology | 0.06 | 480.26K | 0.00% | n/a | 0.00% |
NexImmune Inc. Common Stock | NEXI | Biotechnology | 0.2514 | 350.62K | -23.82% | n/a | 0.00% |
Vaxxinity Inc. Class A Common Stock | VAXX | Biotechnology | 0.002 | 253.57K | 0.00% | n/a | 113.12% |
Navidea Biopharmaceuticals Inc | NAVB | Biotechnology | 0.001 | 100.08K | 0.00% | n/a | -38.49% |
U.S. Stem Cell Inc | USRM | Biotechnology | 0.0001 | 64.15K | 0.00% | n/a | -60.68% |
EFTR | EFTR | Biotechnology | 0.0012 | 5.64K | 0.00% | n/a | 2315.36% |
Calithera Biosciences Inc | CALA | Biotechnology | 0.001 | 4.87K | -50.00% | n/a | 8.17% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.011 | 1.01M | 10.00% | n/a | -37.05% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -0.17 | 0.53 | Cheaper |
Ent. to Revenue | 1.83 | 3,967.00 | Cheaper |
PE Ratio | - | 41.03 | - |
Price to Book | 2.06 | 15.55 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 214.37 | 72.80 | Riskier |
Debt to Equity | 1.31 | -1.23 | Expensive |
Debt to Assets | 0.20 | 0.25 | Cheaper |
Market Cap | 1.30M | 3.66B | Emerging |